Turning Physics into a Diagnostic Signal for Bladder Cancer
A physics-based urine test shows early promise in detecting bladder cancer recurrence without invasive procedures
Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
A physics-based urine test shows early promise in detecting bladder cancer recurrence without invasive procedures
Advances could signal changes for clinical laboratories and at-home testing
The technology has moved from niche to practical for routine diagnostics
The two assays identify threats prior to prostate cancer being diagnosed and after it has undergone extensive treatment, respectively
AMP Annual Meeting attendees showed strong interest in the blood test
SimplyTest’s saliva-based HPV tests will be marketed to dentists and functional medicine practices
Platform enhances the interpretability of CBC-based machine-learning models
The assay detects the presence of three different proteins and is slightly more accurate than a test Quest released earlier this year
Current assays often miss diagnoses in the early stages of the disease, delaying treatment
The initiative is in conjunction with The Gift of Life registry and Doublemint Gum
FDA-approved tests like Intellisep and TriVerity demonstrate potential for early sepsis diagnosis